No Products in the Cart
GET 25% OFF YOUR FIRST ORDER | GREENHOUSE THCA FLOWER 7g - $26.24 $34.99
GET 25% OFF YOUR FIRST ORDER | GREENHOUSE THCA FLOWER 7g - $26.24 $34.99
There is a category of cannabis genetics that exists outside the commercial trend cycle — strains whose value is not defined by the flavor innovation of the season, the latest hybrid cross generating social media enthusiasm, or the potency milestone that temporarily anchors a market segment's attention. These are the strains whose value is defined by therapeutic reliability, by the consistency of a consumer experience built on decades of selective cultivation rather than years of commercial optimization, and by the global patient community that has identified them, tested them across diverse populations and conditions, and returned to them with a loyalty that no marketing program manufactures and no trendier alternative has successfully displaced. DEA-4 is one of those strains. And DEA-4 Greenhouse THCa Trim Wholesale from Ideal Plus Farm brings the full therapeutic depth of Northern Lights × Black Domina × Afghani triple landrace-heritage indica genetics — with 32.64% THCa, 35.04% total cannabinoids, and an exceptionally high 1.83% CBGa medicinal minor cannabinoid profile — to the wholesale trim market at the pricing that makes it genuinely accessible to the full range of operators who should be building finished product programs around its unmatched therapeutic credentials.
Thca wholesale operators building pre-roll programs, medicinal extraction operations, and therapeutic wellness product lines will find in DEA-4 the source material that addresses the core limitation of every other premium indica trim option in the current market: the gap between potency and therapeutic authenticity. High-potency contemporary hybrid genetics produce impressive THCa numbers through trichome density optimization — but the therapeutic experience they deliver, however potent, lacks the specific calming numbness, creative euphoria, and deeply relaxing body weight that decades of patient-community selection pressure has refined in DEA-4's triple landrace heritage. Thca at 32.64% from Northern Lights × Black Domina × Afghani genetics is a fundamentally different therapeutic proposition than 32.64% THCa from a contemporary dessert-forward hybrid — the terpene architecture, the minor cannabinoid profile, and the specific entourage quality that three legendary medicinal indica lineages produce together create consumer experiences that the global patient community has validated across decades of use as genuinely, reliably therapeutic in ways that strain-of-the-season alternatives have not demonstrated.
The 1.83% CBGa figure that DEA-4 delivers alongside 32.64% THCa is among the most significant medicinal minor cannabinoid readings in the Ideal Plus wholesale trim catalog — reflecting the secondary metabolite production depth that triple landrace-heritage genetics carry through their combined evolutionary histories and that modern hybrid genetics, optimized for trichome density and flavor novelty rather than complete cannabinoid biosynthesis, frequently sacrifice. For wholesale thca operators positioning finished products in the therapeutic wellness, pain management, and sleep support market segments — the segments where consumer loyalty is deepest, repeat purchase frequency is highest, and brand advocacy is most powerful — DEA-4's combination of triple landrace medicinal heritage, 32.64% THCa, and 1.83% CBGa creates the source material foundation that the most credible therapeutic finished product programs in the current market are built on.
The genetic architecture of DEA-4 trim material brings together three of the most historically significant, most globally cultivated, and most therapeutically validated indica cultivars in cannabis history — a combination whose sum is not simply the additive value of three individual genetic contributions but a synergistic therapeutic expression that cross-genetic breeding theory predicts and that the global DEA-4 patient community has empirically confirmed.
Northern Lights — possibly the most celebrated pure indica in the history of cannabis cultivation, developed from Afghani and Thai landrace genetics in the Pacific Northwest during the 1970s and '80s, awarded the High Times Cannabis Cup multiple times, and carrying a global therapeutic reputation built on decades of patient use for pain management, insomnia, anxiety, and depression — contributes to DEA-4 the specific calming, deeply physical indica relaxation that defines the strain's most commercially valuable therapeutic dimension. Northern Lights' contribution to DEA-4 is the signature "calming numbness" that the strain's effects description identifies as its most distinctive quality — the specific neurological and physical sedation combination that pain management and insomnia consumer segments specifically seek and that Northern Lights genetics have delivered with greater reliability than virtually any other cannabis cultivar across the entire documented history of therapeutic cannabis use. Northern Lights also contributes the pine forest and earthy-herbal aromatic dimension that grounds DEA-4's terpene profile in the organic, resinous depth of old-world cannabis genetics.
Black Domina — descended from Afghani, Northern Lights, Hash Plant, and Ortega genetics, and known internationally for its exceptionally potent and fast-acting indica effects, its heavy resin production, and its specific reputation for pain-numbing body effects that experienced medical cannabis patients seek when therapeutic need is most acute — contributes the rapid onset character of DEA-4's effects, the dense resin production that enables 32.64% THCa in greenhouse cultivation conditions, and the dark, earthy, spicy aromatic depth that interacts with Northern Lights' pine forest character to produce DEA-4's distinctive earthy herbs and heavy peppery aroma profile. Black Domina's Hash Plant and Ortega heritage specifically contributes the 1.83% CBGa production — the high-resin, broad-spectrum cannabinoid biosynthesis capacity that hash plant genetics carry as a genetic trait selected over generations of traditional cultivation and that translates directly into the full-spectrum entourage quality that makes DEA-4's medicinal experience qualitatively different from potency-equivalent contemporary hybrids.
Afghani — the Central Asian landrace from which virtually all modern indica genetics ultimately descend, carrying the purest expression of the plant's evolved physical-relaxation and pain-management secondary metabolite profile, and representing the genetic foundation that millennia of traditional medicinal use identified as therapeutically valuable before modern biochemistry understood why — contributes to DEA-4 the authentic, irreducible indica depth that no amount of contemporary hybridization can fabricate. The Afghani genetic contribution is the source of DEA-4's most profound and most durable therapeutic quality: the specific body-heaviness and calming numbness that hash-producing landrace genetics evolved over millennia in response to traditional cultivation selection pressure for these precise therapeutic effects.
For thca wholesale distributor operations building client-facing supply programs, DEA-4's Northern Lights × Black Domina × Afghani genetic credentials represent the most therapeutically validated cannabis heritage available in the current domestic wholesale trim market — genetic provenance that communicates decades of medicinal reputation to cannabis-literate consumers without requiring marketing investment to establish.
The three-terpene profile — Beta-Caryophyllene, Limonene, Myrcene — that defines DEA-4's aromatic and therapeutic identity produces the earthy herbs, heavy peppery overtones, and woody pine forest experience that experienced medicinal cannabis consumers associate with the most authentically therapeutic and most deeply effective indica experiences available in the legal hemp marketplace.
Beta-Caryophyllene leads the terpene profile as the most directly therapeutically active component — the unique terpene-cannabinoid hybrid that engages CB2 receptors through the same molecular mechanism as cannabinoids while contributing the spicy-peppery aromatic character that makes DEA-4's aroma immediately recognizable as a medicine-grade, heritage-genetics indica rather than a flavor-forward commercial hybrid. Caryophyllene's anti-inflammatory CB2 activity is among the most studied and most evidence-supported of any cannabis terpene's therapeutic mechanisms — contributing directly measurable anti-inflammatory effects alongside the aromatic and flavor character that defines DEA-4's most distinctive and most medicinally communicative sensory dimension. For therapeutic wellness finished products, caryophyllene leadership in the source material terpene profile is a direct and authentic therapeutic quality claim that medical-adjacent positioning specifically requires. Limonene provides the brightness that lifts the heavy earthy-pepper foundation into the complete, nuanced profile that makes DEA-4 aromatically sophisticated rather than one-dimensionally pungent — and contributes the mood-elevating, euphoric effects dimension that produces the creative euphoria component of DEA-4's effects alongside the deeper physical relaxation. The creative-euphoric quality that makes DEA-4 unique among deeply relaxing indica strains — the touch of mental engagement and happy thoughts that prevents complete cognitive sedation — traces directly to limonene's interaction with the dominant caryophyllene and myrcene physical-relaxation terpene combination. Myrcene delivers the deep earthy sweetness, the herbal complexity, and the most profound physical relaxation depth in DEA-4's effects profile — the terpene whose combination with Northern Lights and Afghani indica genetics produces the specific calming numbness that distinguishes DEA-4's therapeutic experience from less deeply relaxing indica alternatives.
The 1.83% CBGa functions not only as a potent minor cannabinoid therapeutic contributor in its own right but as the entourage quality amplifier that elevates the combined caryophyllene-limonene-myrcene therapeutic expression beyond what the THCa content alone would produce. The interaction of 32.64% THCa, 1.83% CBGa, and the three-terpene medicinal profile creates the specific "crazy high medicinal value" that the global patient community has identified and validated in DEA-4 — an experience quality that source material data can document but that the consumer community's decades of therapeutic use most credibly confirms. Thca bulk material with this specific therapeutic terpene and cannabinoid combination is among the most medically significant source material inputs available in the current domestic wholesale trim market.
The "Ultra-Premium Medicinal Grade" designation that DEA-4's 35.04% total cannabinoid content warrants is not simply a marketing characterization — it reflects a specific and meaningful quality distinction that separates DEA-4 from the broader premium trim market in ways that wholesale operators building therapeutic wellness programs should understand in direct commercial terms.
At 35.04% total cannabinoids — anchored by 32.64% THCa and substantively supported by 1.83% CBGa, 0.18% CBG, 0.16% CBDa, and 0.23% Delta-9 THC — DEA-4 occupies the top tier of the Ideal Plus wholesale trim catalog by total cannabinoid content, exceeded only by the highest-THCa single-metric strains while surpassing them in minor cannabinoid diversity. The distinction matters for therapeutic product positioning because consumer-facing medicinal quality claims are most credibly supported by total cannabinoid breadth rather than single-metric THCa maximization — the combined therapeutic contribution of the full cannabinoid profile is what produces the entourage quality that patient communities report as clinically meaningful, and that premium medical-adjacent wellness product marketing most authentically communicates.
For thca wholesale deals evaluation purposes, DEA-4's 35.04% total cannabinoid content at its wholesale pricing creates a cost-per-total-cannabinoid metric that makes it among the most economically efficient premium therapeutic source material inputs in the Ideal Plus catalog — delivering not just THCa but the complete minor cannabinoid therapeutic profile that sophisticated medicinal finished product positioning requires, in a single source material rather than requiring supplementary minor cannabinoid addition at the production stage.
The decarboxylation conversion metric — THCa converts to Delta-9 THC at approximately 87.7% efficiency — means that DEA-4's 32.64% THCa represents approximately 28.6% Delta-9 THC equivalent in combusted or vaporized applications, positioning DEA-4 pre-rolls and flower products at the very top of the potency category that medicinal consumers prioritize for serious therapeutic applications.
Therapeutic Pre-Roll Programs: DEA-4 trim's triple landrace medicinal heritage, 32.64% THCa potency, and earthy-pepper-pine flavor profile create a pre-roll source material specifically optimized for the therapeutic wellness pre-roll consumer — the demographic that purchases pre-rolls for genuine medical purpose rather than recreational occasion and whose loyalty is earned by consistent therapeutic reliability rather than flavor novelty or packaging appeal. The global patient community reputation that DEA-4 carries translates into retail pre-roll brand credibility that generic indica alternatives cannot claim. Thca flower trim with DEA-4's medicinal genetics and potency creates premium therapeutic pre-rolls that compete on authentic medical heritage rather than simply on potency numbers.
Medicinal Full-Spectrum Extraction: The 1.83% CBGa, 0.18% CBG, 32.64% THCa, and caryophyllene-dominant anti-inflammatory terpene profile create a source material cannabinoid and terpene matrix of exceptional medicinal extraction value. Full-spectrum rosin and live resin from DEA-4 carries the complete triple landrace medicinal heritage in concentrated form — the entourage quality that makes patient-community-validated therapeutic experiences reproducible in extract format. For operators positioning medicinal-grade full-spectrum extracts in dispensary and wellness retail channels, DEA-4's heritage and cannabinoid depth create the most credible "medicinal grade" source material narrative in the Ideal Plus trim catalog. Thca trim bulk with 1.83% CBGa in a triple landrace 80% indica cultivar is genuinely exceptional in the domestic wholesale trim market.
Pain Management and Sleep Support Products: DEA-4's specific calming numbness effects profile — the neurological and physical sedation combination that Northern Lights, Black Domina, and Afghani genetics collectively produce — makes it the premier source material in the Ideal Plus trim catalog for finished products specifically positioned for pain management and sleep support applications. Tinctures, capsules, and topicals made from DEA-4 source material carry the authentic therapeutic heritage that pain management and sleep support consumer segments specifically seek, supported by the 1.83% CBGa anti-inflammatory minor cannabinoid depth and the caryophyllene CB2 anti-inflammatory activity that evidence-based therapeutic positioning most credibly requires. Thca shake and trim from DEA-4's proven medicinal genetics is the natural foundation for the most medically credible therapeutic product lines in any hemp wellness program.
Specialty Therapeutic Blends: For operators creating proprietary therapeutic blend products — combining multiple strain trim materials into specific effects-profile finished products — DEA-4 functions as the anchor medicinal indica component that elevates blend therapeutic depth and provides the triple landrace heritage quality narrative that distinguishes "therapeutic blend" positioning from generic multi-strain alternatives. The specific calming numbness and deep relaxation character of DEA-4 blends with complementary source materials in ways that preserve its most therapeutically significant qualities while broadening the effects profile for diverse consumer application.
Ideal Plus Farm offers DEA-4 Greenhouse THCa Trim Wholesale across the full range of production scale configurations — from thca trim pound evaluation quantities for new accounts assessing DEA-4's medicinal quality and finished product performance to thca trim pounds multi-pound and bulk supply configurations for established therapeutic production operations requiring consistent high-volume supply.
$100/lb thca trim and above pricing tiers from Ideal Plus Farm reflect the cultivation investment, triple landrace genetic heritage, hand-trimmed processing standard, and comprehensive testing documentation that make DEA-4 a genuine ultra-premium medicinal source material rather than a commodity product at premium pricing. Trim wholesale procurement for therapeutic wellness programs should evaluate DEA-4 on cost-per-unit-of-therapeutic-quality rather than cost-per-pound input — the consumer loyalty that authentic triple landrace medicinal effects generate, the premium positioning that 35.04% total cannabinoid content and 1.83% CBGa enable, and the therapeutic reputation that Northern Lights × Black Domina × Afghani genetics carry into every finished product that communicates that heritage all justify the procurement premium over commodity or single-heritage indica trim alternatives.
Every DEA-4 wholesale order ships with comprehensive quality documentation: Certificates of Analysis from accredited independent laboratories covering the complete cannabinoid panel, terpene quantification, pesticide residue testing, heavy metal analysis, microbial contamination screening, and residual solvent panels. The 0.23% Delta-9 THC confirms federal Farm Bill compliance. Contact the Ideal Plus wholesale team for current thca trim wholesale pricing, volume tier structures, and account qualification requirements.
Maintaining DEA-4 trim's 32.64% THCa potency, 1.83% CBGa medicinal minor cannabinoid content, and earthy-pepper-pine terpene profile through storage and production requires the environmental standards that all medicinal-grade premium trim material benefits from — with particular attention to the caryophyllene terpene stability that defines the most therapeutically active aromatic dimension.
Thca trim cheap alternatives with inadequate post-harvest handling frequently arrive with compromised terpene integrity — the medicinal aromatic character that distinguishes authentic landrace-heritage indica trim degraded through oxygen exposure and temperature instability. Ideal Plus Farm's controlled post-harvest handling preserves DEA-4's complete therapeutic profile through delivery, and wholesale operators should maintain those conditions: airtight containers, 58–62% relative humidity, cool stable-temperature environments protected from direct light exposure.
The beta-caryophyllene and myrcene fractions that define DEA-4's most therapeutically significant terpene dimensions are among the more stable cannabis terpene families under proper storage conditions — maintaining their earthy-peppery medicinal character through production planning timelines with appropriate humidity management. Limonene's brightness is more volatile, requiring attentive oxygen sealing to preserve its contribution to the creative-euphoric effects dimension. Thca shake trim stored and handled correctly delivers the complete medicinal terpene and cannabinoid profile that the source material testing documents — ensuring that finished products carry the therapeutic quality that the triple landrace heritage promises.
1. What makes DEA-4 trim's "crazy high medicinal value" claim credible rather than simply marketing language? DEA-4's medicinal value claim is grounded in the documented global patient community validation that Northern Lights × Black Domina × Afghani genetics have accumulated across decades of therapeutic use — the same validation process that established Northern Lights as one of the most celebrated medicinal indica cultivars in cannabis history. The specific combination of 32.64% THCa, 1.83% CBGa, caryophyllene CB2 anti-inflammatory terpene leadership, and triple landrace entourage quality produces the calming numbness and deep therapeutic relaxation that patient communities across diverse medical applications have identified as clinically meaningful. This is not a marketing claim applied to a generic indica but an accurate reflection of a strain's documented therapeutic reputation.
2. How does the triple landrace heritage specifically improve therapeutic quality over contemporary hybrid trim? Triple landrace heritage genetics carry decades of selection pressure specifically for therapeutic cannabinoid and terpene production — the complete secondary metabolite diversity that traditional medicinal cannabis cultivation optimized for treatment efficacy rather than flavor novelty or commercial potency maximization. DEA-4's Northern Lights, Black Domina, and Afghani parent genetics each contributed specific therapeutic qualities refined through generations of patient-community selection, producing in their combination an entourage quality that contemporary hybrid genetics, however potent, have not replicated with the same therapeutic depth or the same reliability of consumer experience across the diverse medical application contexts that the global DEA-4 patient community represents.
3. Is DEA-4 trim federally legal? Yes. DEA-4 Greenhouse THCa Trim Wholesale is produced in full federal Farm Bill compliance, with Delta-9 THC confirmed at 0.23% by dry weight through accredited independent laboratory testing — within the 0.3% federal threshold. Complete compliance documentation including independent COA ships with every wholesale order as standard documentation.
4. What therapeutic conditions is DEA-4 most commonly associated with in patient communities globally? The global DEA-4 patient community reports consistent therapeutic effectiveness for chronic pain management, severe stress and anxiety relief, mood stabilization, depression management, inflammation reduction, insomnia treatment, and chronic fatigue. The calming numbness effects are specifically associated with pain management applications; the deep relaxation with insomnia and stress relief; and the creative euphoric component with mood support and depression management. Note that hemp products are not FDA-approved for medical treatment — these associations reflect community-reported use patterns rather than clinical medical claims. Consult healthcare providers for medical treatment guidance.
5. How does 1.83% CBGa specifically benefit medicinal product applications? CBGa contributes anti-inflammatory, neuroprotective, antibacterial, and appetite-modulating properties studied in emerging cannabis research, adding meaningful therapeutic breadth to finished products made from DEA-4 source material. In combination with 32.64% THCa and the caryophyllene CB2 anti-inflammatory terpene activity, DEA-4's 1.83% CBGa creates a multi-mechanism anti-inflammatory therapeutic profile that single-cannabinoid alternatives cannot match. For thca trim and shake extraction operators building medicinal-grade full-spectrum products, 1.83% CBGa at 32.64% THCa potency is the source material specification that authentic medicinal positioning requires.
6. What finished product potency does 32.64% THCa source material enable? Pre-rolls and combusted finished products from 32.64% THCa DEA-4 source material carry potency figures in the ultra-premium retail tier — approximately 28.6% Delta-9 THC equivalent after decarboxylation at 87.7% conversion efficiency. This positions DEA-4 pre-rolls at the very top of the medicinal potency category that serious therapeutic consumers specifically seek for conditions requiring the most substantial cannabinoid delivery.
7. What documentation ships with DEA-4 trim wholesale orders? Every wholesale order ships with Certificates of Analysis from accredited independent laboratories covering the complete cannabinoid panel — including 32.64% THCa, 1.83% CBGa, 0.18% CBG, 0.16% CBDa, and 0.23% Delta-9 THC — terpene quantification across the three-terpene profile, pesticide residue testing, heavy metal analysis, microbial contamination screening, and residual solvent panels. Federal Farm Bill compliance documentation and organic cultivation records are standard inclusions with all thca wholesale deals from Ideal Plus Farm.
8. How should DEA-4 trim be stored to maintain medicinal-grade quality through production cycles? Store in airtight containers with humidity control packs at 58–62% relative humidity in a cool, stable-temperature, dark environment. The caryophyllene and myrcene fractions that define DEA-4's medicinal aromatic depth are among the more stable cannabis terpene families — maintaining their earthy-peppery-pine character well through proper storage. Limonene is more volatile and requires attentive oxygen sealing. Proper storage conditions maintain the 1.83% CBGa integrity as well as THCa potency through production planning timelines.
9. What extraction methodology best preserves DEA-4's medicinal terpene and cannabinoid profile? Rosin and low-temperature live resin extraction preserve DEA-4's complete caryophyllene-limonene-myrcene terpene architecture alongside the 1.83% CBGa full-spectrum minor cannabinoid content with the highest fidelity — producing finished medicinal extracts with the authentic triple landrace therapeutic depth that DEA-4's heritage promises. Cold-temperature ethanol extraction provides high-throughput processing with good terpene and cannabinoid preservation for large-scale medicinal production operations.
10. What minimum order quantities are available for DEA-4 trim? Contact the Ideal Plus wholesale team for current minimum order requirements, thca trim pound entry pricing, and volume tier structures for the DEA-4 wholesale program. Ideal Plus Farm accommodates operators from boutique therapeutic evaluation quantities through high-volume medicinal production supply configurations.
11. How does the 80/20 indica-sativa balance affect DEA-4's therapeutic application range? The 80% indica dominance produces the profound physical calming numbness and deep relaxation that serious pain management, inflammation, and insomnia applications require — the therapeutic depth that less indica-dominant alternatives provide less completely. The 20% sativa component contributes the creative euphoria and mental engagement that prevents complete cognitive sedation, making DEA-4 appropriate for daytime therapeutic use in conditions where pain relief without full sedation is required and distinguishing it from pure indica source materials that limit finished products to exclusively nighttime positioning.
12. Can operators build sleep support product lines specifically around DEA-4? Yes, with DEA-4's calming numbness and deep relaxation effects profile making it arguably the most credible sleep support source material in the Ideal Plus trim catalog. The myrcene-dominant terpene physical relaxation depth, the Northern Lights heritage specifically associated with insomnia relief, and the 32.64% THCa potency for substantial therapeutic delivery combine to make DEA-4 the natural foundation for sleep support tinctures, capsules, and pre-roll products that require authentic indica therapeutic depth rather than simply adequate potency for credible consumer positioning. Bulk thca trim from DEA-4's triple landrace genetics is the premium sleep support source material input in the domestic greenhouse trim market.
13. How does DEA-4 compare to Gassa Purple in therapeutic positioning? Both DEA-4 and Gassa Purple are premium therapeutic indica trim options in the Ideal Plus catalog, with meaningful quality distinctions for different therapeutic positioning requirements. DEA-4 carries higher THCa at 32.64% versus Gassa Purple's 30.59%, higher total cannabinoids at 35.04% versus 32.99%, and the triple landrace medicinal heritage credibility that positions it specifically in the ultra-premium medicinal grade category. Gassa Purple's 60/40 indica-sativa balance provides greater daytime versatility and broader occasion positioning; DEA-4's 80/20 heavy indica dominance provides deeper therapeutic heaviness for the most serious pain management and sleep support applications. Both strains offer outstanding CBGa content — DEA-4 at 1.83% and Gassa Purple at 1.78%.
14. Can operators sample DEA-4 trim before placing volume orders? Ideal Plus Farm accommodates sample requests for qualified wholesale buyers evaluating DEA-4 for medicinal production programs. Contact the Ideal Plus wholesale team to discuss sample availability, qualification requirements, and documentation included with evaluation orders.
15. Where can I order DEA-4 Greenhouse THCa Trim Wholesale? The complete Ideal Plus Farm thca wholesale trim catalog — including DEA-4 and all currently available greenhouse trim strains — is available at tryidealplus.com/collections/thca-trim. Wholesale inquiries, volume pricing, and account setup can be initiated directly through the site or by contacting the Ideal Plus sales team for personalized wholesale program support.
The most therapeutically credible finished hemp products in the current market are not built on the highest single-metric THCa figure or the most Instagram-worthy flavor novelty — they are built on the kind of genetic heritage, cannabinoid depth, and global therapeutic validation that the cannabis community has accumulated over decades of patient use and that no amount of contemporary hybridization has reproduced with comparable reliability. DEA-4 Greenhouse THCa Trim Wholesale from Ideal Plus Farm carries that heritage in every trim piece from every production batch — the Northern Lights calming depth, the Black Domina resin intensity, the Afghani landrace authenticity, unified at 32.64% THCa and 1.83% CBGa in Ideal Plus Farm's premium Oregon greenhouse environment.
For operators building the therapeutic wellness pre-roll programs that dispensary buyers specifically allocate shelf space for, for medicinal extract producers who need full-spectrum cannabinoid depth that 35.04% total cannabinoid content from triple landrace genetics provides, for sleep and pain management product developers whose consumers are the most medically sophisticated and most loyalty-generating demographic in the hemp market — DEA-4 is the source material that makes genuine medicinal positioning possible at premium quality levels throughout every production cycle. Explore the complete thca wholesale deals catalog at Ideal Plus Farm and discover why DEA-4 has established itself as the definitive medicinal-grade indica trim offering in the Oregon greenhouse wholesale program — the source material that the global patient community has validated and that the most credible therapeutic finished product programs are built on.
All products on this website contain .3% THC Delta-9 or less. No statement in this website has been evaluated by the Food and Drug Administration (FDA). Furthermore, none of the statements in this website should be construed as dispensing medical advice or making claims regarding the cure of diseases.
